These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20209935)

  • 21. Mass spectrometric analysis of cytosine methylation by base-specific cleavage and primer extension methods.
    van den Boom D; Ehrich M
    Methods Mol Biol; 2009; 507():207-27. PubMed ID: 18987817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.
    Gonzalez-Gomez P; Bello MJ; Inda MM; Alonso ME; Arjona D; Amiñoso C; Lopez-Marin I; de Campos JM; Sarasa JL; Castresana JS; Rey JA
    Oncol Rep; 2004 Sep; 12(3):663-6. PubMed ID: 15289853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutations.
    Tomatsu S; Sukegawa K; Trandafirescu GG; Gutierrez MA; Nishioka T; Yamaguchi S; Orii T; Froissart R; Maire I; Chabas A; Cooper A; Di Natale P; Gal A; Noguchi A; Sly WS
    Eur J Hum Genet; 2006 Jul; 14(7):838-45. PubMed ID: 16617305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental research on DNA methylation profile in congenital microtia].
    Song YP; Lin L; Pan B; Yang QH; Han J; Jiang HY; Zhuang HX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):193-8. PubMed ID: 22870707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient with an EYA1 mutation with features of branchio-oto-renal and oto-facio-cervical syndrome.
    Mercer C; Gilbert R; Loughlin S; Foulds N
    Clin Dysmorphol; 2006 Oct; 15(4):211-212. PubMed ID: 16957474
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenocarcinoma in the ileal pouch: early detection and potential role of fecal DNA methylated markers in surveillance.
    Obusez EC; Liu Y; Bennett AE; Remzi FH; Guo B; Shen B
    Int J Colorectal Dis; 2011 Jul; 26(7):951-3. PubMed ID: 20963426
    [No Abstract]   [Full Text] [Related]  

  • 31. Methylation of the phosphatase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies.
    Li X; Eberhardt A; Hansen JN; Bohmann D; Li H; Schor NF
    FASEB J; 2017 Jun; 31(6):2327-2339. PubMed ID: 28213359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germinal mosaicism in a family with BO syndrome.
    Miyagawa M; Nishio SY; Hattori M; Takumi Y; Usami S
    Ann Otol Rhinol Laryngol; 2015 May; 124 Suppl 1():118S-22S. PubMed ID: 25780253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis.
    Field J; Fox A; Jordan MA; Baxter AG; Spelman T; Gresle M; Butzkueven H; Kilpatrick TJ; Rubio JP
    Genes Immun; 2017 Mar; 18(2):59-66. PubMed ID: 28077880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preeclampsia is Associated with Decreased Methylation of the GNA12 Promoter.
    Ye W; Shen L; Xiong Y; Zhou Y; Gu H; Yang Z
    Ann Hum Genet; 2016 Jan; 80(1):7-10. PubMed ID: 26767593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of two major loci that suppress hearing loss and cochlear dysmorphogenesis in Eya1bor/bor mice.
    Niu H; Makmura L; Shen T; Sheth SS; Blair K; Friedman RA
    Genomics; 2006 Sep; 88(3):302-8. PubMed ID: 16488112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial transmission of oculoauriculovertebral spectrum (Goldenhar syndrome) is not due to mutations in either EYA1 or SALL1.
    Goodin K; Prucka S; Woolley AL; Kohlhase J; Smith RJ; Grant J; Robin NH
    Am J Med Genet A; 2009 Mar; 149A(3):535-8. PubMed ID: 19213029
    [No Abstract]   [Full Text] [Related]  

  • 37. Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Garate L; Jose-Eneriz ES; Cordeu L; Barrios M; Prosper F; Heiniger A; Torres A
    Leukemia; 2006 Aug; 20(8):1445-8. PubMed ID: 16688225
    [No Abstract]   [Full Text] [Related]  

  • 38. The genes for sensory perception of sound should be considered in gene diagnosis of congenital sensorineural hearing loss and microtia.
    Lin K; You DY; Zhang LH; Zhou LJ; Zu JY; Xiao Y; Sun MH; Dong-Su ; Cao X; Zhang TS; Ma J
    J Appl Genet; 2022 May; 63(2):327-337. PubMed ID: 35000142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel EYA1 mutation presenting in a newborn with laryngomalacia, glossoptosis, retrognathia, and pectus excavatum.
    Spruijt L; Hoefsloot LH; van Schaijk GH; van Waardenburg D; Kremer B; Brackel HJ; de Die-Smulders CE
    Am J Med Genet A; 2006 Jun; 140(12):1343-5. PubMed ID: 16691597
    [No Abstract]   [Full Text] [Related]  

  • 40. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.
    Chanudet E; Huang Y; Ichimura K; Dong G; Hamoudi RA; Radford J; Wotherspoon AC; Isaacson PG; Ferry J; Du MQ
    Leukemia; 2010 Feb; 24(2):483-7. PubMed ID: 19907439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.